Swiss National Bank’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.67M Buy
251,400
+33,600
+15% +$444K ﹤0.01% 1616
2026
Q1
$3M Hold
217,800
﹤0.01% 1638
2025
Q4
$3.93M Buy
217,800
+7,700
+4% +$138K ﹤0.01% 1490
2025
Q3
$3.89M Buy
210,100
+3,000
+1% +$47.1K ﹤0.01% 1462
2025
Q2
$3.31M Buy
207,100
+15,800
+8% +$282K ﹤0.01% 1514
2025
Q1
$3.72M Buy
191,300
+40,700
+27% +$857K ﹤0.01% 1427
2024
Q4
$3.32M Buy
150,600
+29,600
+24% +$570K ﹤0.01% 1549
2024
Q3
$2.04M Sell
121,000
-1,100
-0.9% -$16.3K ﹤0.01% 1844
2024
Q2
$1.46M Buy
122,100
+24,500
+25% +$274K ﹤0.01% 1973
2024
Q1
$1.08M Hold
97,600
﹤0.01% 2181
2023
Q4
$845K Sell
97,600
-10,200
-9% -$79.3K ﹤0.01% 2333
2023
Q3
$825K Buy
107,800
+25,300
+31% +$190K ﹤0.01% 2346
2023
Q2
$594K Hold
82,500
﹤0.01% 2507
2023
Q1
$502K Sell
82,500
-6,500
-7% -$35.2K ﹤0.01% 2518
2022
Q4
$388K Hold
89,000
﹤0.01% 2620
2022
Q3
$349K Hold
89,000
﹤0.01% 2650
2022
Q2
$454K Hold
89,000
﹤0.01% 2635
2022
Q1
$570K Buy
89,000
+6,300
+8% +$41.8K ﹤0.01% 2572
2021
Q4
$663K Buy
+82,700
New +$779K ﹤0.01% 2600

Other funds holding CLBT

Swiss National Bank's CLBT Position: Q2 2026 in Review

Swiss National Bank increased its Cellebrite (CLBT) stake by 15% in Q2 2026, buying an estimated $444K and bringing the position to 251,400 shares worth $3.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1616.

Swiss National Bank first reported a position in CLBT in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.93M in Q4 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Swiss National Bank held 251,400 shares of Cellebrite worth $3.67M as of Q2 2026.
  • Swiss National Bank bought 33,600 Cellebrite shares in Q2 2026, an estimated $444K.
  • Cellebrite made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1616 holding.
  • Swiss National Bank first reported a position in Cellebrite in Q4 2021 and has held it in 19 quarters since.
  • Swiss National Bank's Cellebrite position peaked at $3.93M in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.